Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Article in English | LILACS-Express | LILACS | ID: biblio-1529456

ABSTRACT

ABSTRACT The global reemergence of measles in 2018-2019 reinforces the relevance of high-coverage immunization to maintain the disease elimination. During an outbreak in the Sao Paulo State in 2019, several measles cases were reported in individuals who were adequately vaccinated according to the current immunization schedule recommends. This study aimed to assess measles IgG antibody seropositivity and titers in previously vaccinated adults. A cross-sectional study was conducted at CRIE-HC-FMUSP (Sao Paulo, Brazil) in 2019. It included healthy adults who had received two or more Measles-Mumps-Rubella vaccines (MMR) and excluded individuals with immunocompromising conditions. Measles IgG antibodies were measured and compared by ELISA (Euroimmun®) and chemiluminescence (LIASON®). The association of seropositivity and titers with variables of interest (age, sex, profession, previous measles, number of measles-containing vaccine doses, interval between MMR doses, and time elapsed since the last MMR dose) was analyzed. A total of 162 participants were evaluated, predominantly young (median age 30 years), women (69.8%) and healthcare professionals (61.7%). The median interval between MMR doses was 13.2 years, and the median time since the last dose was 10.4 years. The seropositivity rate was 32.7% by ELISA and 75.3% by CLIA, and a strong positive correlation was found between the tests. Multivariate analyses revealed that age and time since the last dose were independently associated with positivity. Despite being a single-center evaluation, our results suggest that measles seropositivity may be lower than expected in adequately immunized adults. Seropositivity was higher among older individuals and those with a shorter time since the last MMR vaccine dose.

2.
Rev. Soc. Bras. Med. Trop ; 40(2): 156-162, mar.-abr. 2007. tab, graf
Article in English | LILACS | ID: lil-452615

ABSTRACT

We analyzed the kinetics of cytokine production by mononuclear cells from 17 patients who had been treated for paracoccidioidomycosis, using the stimulus of gp43 peptide groups (43kDa glycoprotein of Paracoccidioides brasiliensis) at 0.1 and 1µM, gp43 (1µg/ml) and crude Paracoccidioides brasiliensis antigen (PbAg; 75µg/ml). IFN-gamma production was a maximum at 144 hours in relation to the G2 and G8 peptide groups at 1µM and was greatest at 144 hours when stimulated by gp43 and by PbAg. The maximum TNF-alpha production was at 144 hours for the G2 group (0.1µM) and for gp43. IL-10 production was highest after 48 and 72 hours for G7 and G6 at 1µM, respectively. We also suggest the best time for analysis of IL4 production. These results may contribute towards future studies with gp43 peptides and encourage further investigations with the aim of understanding the influence of these peptides on the production of inflammatory and regulatory cytokines.


Analisamos a cinética da produção de citocinas de células mononucleares de 17 pacientes com paracoccidioidomicose tratada, usando como estímulo: grupos de peptídeos da gp43 (glicoproteina de 43kDa de Paracoccidioides brasiliensis) a 0,1 e 1µM, gp43 (1µg/mL) e antígeno bruto de Paracoccidioides brasiliensis - AgPb (75µg/mL). A produção de IFN-gama foi máxima em 144 horas frente aos grupos de peptídeos G2 e G8 a 1µM e maior em 144 horas quando estimuladas por gp43 e por AgPb. A produção de TNF-alfa foi máxima em 144 horas para G2 (0,1µM) e para gp43. A produção de IL-10 foi maior após 48 e 72 horas para G7 e G6 a 1µM, respectivamente. Sugerimos também o melhor período para a análise da produção de IL4. Tais resultados podem contribuir para estudos com peptídeos da gp43, estimulando investigações posteriores visando entender a influência de tais peptídeos na produção de citocinas inflamatórias e regulatórias.


Subject(s)
Humans , Cytokines/biosynthesis , Fungal Proteins/pharmacology , Leukocytes, Mononuclear/immunology , Paracoccidioides/chemistry , Paracoccidioidomycosis/immunology , Fungal Proteins/isolation & purification , Interferon-gamma/biosynthesis , /biosynthesis , /biosynthesis , Leukocytes, Mononuclear/drug effects , Paracoccidioides/immunology , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
3.
Rev. Inst. Med. Trop. Säo Paulo ; 43(5): 257-261, Sept.-Oct. 2001. ilus, tab
Article in English | LILACS | ID: lil-307998

ABSTRACT

In order to study B. henselae transmission among cats, five young cats were kept in confinement for two years, one of them being inoculated by SC route with B. henselae (10(5) UFC). Only occasional contact among cats occurred but the presence of fleas was observed in all animals throughout the period. Blood culture for isolation of bacteria, PCR-HSP and FTSZ (gender specific), and BH-PCR (species-specific), as well as indirect immunofluorescence method for anti-B. henselae antibodies were performed to confirm the infection of the inoculated cat as well as the other naive cats. Considering the inoculated animal, B. henselae was first isolated by blood culture two months after inoculation, bacteremia last for four months, the specific antibodies being detected by IFI during the entire period. All contacting animals presented with bacteremia 6 months after experimental inoculation but IFI did not detect seroconversion in these animals. All the isolates from these cats were characterized as Bartonella (HSP and FTSZ-PCR), henselae (BH-PCR). However, DNA of B. henselae could not be amplified directly from peripheral blood by the PCR protocols used. Isolation of bacteria by blood culture was the most efficient method to diagnose infection compared to PCR or IFI. The role of fleas in the epidemiology of B. henselae infection in cats is discussed


Subject(s)
Animals , Cats , Antibodies, Bacterial , Bartonella henselae , Bartonella Infections , Cat Diseases , Bartonella henselae , Bartonella Infections , Cat Diseases , Culture Media , Disease Transmission, Infectious , DNA, Bacterial , Fluorescent Antibody Technique, Indirect , Polymerase Chain Reaction , Sensitivity and Specificity
4.
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo ; 53(6): 303-10, nov.-dez. 1998. tab, ilus
Article in Portuguese | LILACS | ID: lil-240800

ABSTRACT

Com objetivo de verificar o comportamento imunologico do recem-nascido (RN) frente a um agravo infeccioso, estudamos 60 RN que apresentavam fatores de risco para infeccao precoce (ruptura prematura de membranas, amnionite clinica, ou infeccao do trato urinario) do ponto de vista infeccioso e imunologico. Todos foram classificados em tres grupos de idade gestacional : inferior a 34 semanas, entre 34 e 36 6/7 semanas e > 37 semanas. O diagnostico de sepse foi realizado atraves de criterios clinicos e laboratorias, incluindo-se entre os exames as dosagens de imunoglobulinas (IgG, IgM, IgA) e complemento total (CH50), obtidos do RN ao nascimento e no quinto dia de vida...


Subject(s)
Humans , Male , Female , Immunoglobulins/analysis , Risk Factors , Sepsis/immunology , Case-Control Studies , Complement System Proteins/analysis , Gestational Age
5.
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo ; 53(1): 21-5, jan.-fev. 1998. ilus, tab
Article in Portuguese | LILACS | ID: lil-211752

ABSTRACT

O angioedema hereditario e uma doenca decorrente de alteracoes na concentracao ou na cavidade do inibidor de C1 esterase (C1INH). Sua ocorrencia e rara e esta associada a heranca autossomica dominante. Os autores descrevem sete pacientes (4M:3F) portadores de deficiencia nas concentracoes de C1INH, com idade de 12 a 50 anos, sendo quatro pacientes pertencentes a mesma familia. As principais manifestacoes clinicas foram: angioedema de face, maos e pes (6/7) e dores abdominais (2/7). Os sintomas nao se relacionam com fatores desencadeantes na maioria dos pacientes (4/7), sendo trauma (2/7) e ciclo menstrual (1/7) referidos pelos outros. Como complicacao, antes do diagnostico, um dos pacientes foi submetido a laparotomia, com resseccao intestinal...


Subject(s)
Humans , Adolescent , Adult , Middle Aged , Angioedema/diagnosis , Angioedema/genetics , Angioedema/therapy , Complement C1s/analysis , Complement Hemolytic Activity Assay , Danazol , Danazol/therapeutic use , Laparotomy , Medical History Taking
SELECTION OF CITATIONS
SEARCH DETAIL